PHAR Stock Price Prediction 2026-2027

AI-powered forecast for Pharming Group NV

Based on fundamental analysis and historical trends

Data Updated:

Current Price

$0.00

Price Targets for 2027

Bear Case

$0.00

NaN%

Base Case

$0.00

NaN%

Bull Case

$0.00

NaN%

Prediction Tracking

Coming Soon for PHAR

Tracking begins January 2026

We are building a comprehensive track record of our AI predictions. Check back to see how our forecasts perform against actual results.

Upcoming Events for PHAR

Key Factors Influencing PHAR Stock

Bullish Factors

  • Market position and competitive advantages

Risk Factors

  • Market volatility and macroeconomic factors
  • Competitive pressures in Biotechnology

Prediction Methodology

These predictions are generated using fundamental analysis including:

    Limited analyst coverage available. Consider viewing more research before making investment decisions.

    Get Real-Time Analysis

    Access live data, AI insights, and detailed valuations for PHAR

    Frequently Asked Questions

    What is PHAR stock price today?

    Visit our real-time dashboard for the current PHAR stock price and live market data.

    Is PHAR stock going up or down today?

    PHAR stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

    Should I buy PHAR stock now?

    The decision to buy PHAR depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

    Is PHAR a buy, hold, or sell right now?

    Our AI-powered analysis provides buy/hold/sell recommendations for PHAR based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

    Is PHAR stock overvalued or undervalued?

    Use our DCF valuation calculator to determine if PHAR is overvalued or undervalued based on fundamental analysis and future cash flow projections.

    What is PHAR's P/E ratio?

    P/E ratio data for PHAR will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

    What is PHAR's market cap?

    PHAR (Pharming Group NV) has a market capitalization of $0.72 billion, making it a small-cap stock.

    What is PHAR's price to book ratio?

    Price-to-book ratio for PHAR is available on our dashboard along with other valuation metrics.

    Does PHAR pay dividends?

    PHAR does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

    What is PHAR's dividend yield?

    PHAR does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

    Is PHAR stock a good long-term investment?

    PHAR's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

    What is PHAR's revenue growth rate?

    Revenue growth data for PHAR is available on our dashboard with detailed financial statement analysis.

    Is PHAR profitable?

    Profitability metrics for PHAR are available on our dashboard with complete income statement analysis.

    What are the risks of investing in PHAR?

    Key risks for PHAR include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

    How does PHAR compare to its competitors?

    Compare PHAR to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize PHAR's performance and positioning.

    What is PHAR's stock price target for 2026?

    Visit our prediction page for AI-powered price targets for PHAR with bull, base, and bear case scenarios.

    What do analysts say about PHAR?

    Wall Street analysts provide ratings (buy/hold/sell) and price targets for PHAR. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

    When is PHAR's next earnings report?

    PHAR reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

    Explore Categories